1) type I collagen cross-linked C-terminal telopeptide
I型胶原交联羧基末端肽
2) C-telopeptide of type I col
I型胶原羧基端末肽
3) Urinary type Ⅰcollagen cross-linked N-telopeptides(uNTX)
I型胶原交联氨基末端肽
4) Type I collagen cross linked N telopeptides in urine
尿I型胶原交联氨基末端肽
5) ICTP
Ⅰ型胶原交联羧基末端肽
1.
Objective: To evaluate the benefits of using new bone metabolic markers such as urinary pyridinoline cross-linked N-telopeptides of Type I collagen (NTx) and serum pyridinoline cross-linked C-telopeptides of Type I collagen (ICTP) in the detection of bone metastasis in patients with malignant tumors.
目的:探讨溶骨性骨代谢生化指标尿Ⅰ型胶原交联氨基末端肽(NTx)、血Ⅰ型胶原交联羧基末端肽(ICTP)定量检测诊断恶性肿瘤骨转移的价值。
2.
Objective To study the clinical usefulness of determination of serum carboxy terminal telepeptide typeⅠ collagen (ICTP) and aminoterminal prepeptide typeⅠ procollagen (PINP) in cancer patients with bone metastasis for diagnosis and treatment.
目的 :探讨Ⅰ型胶原交联羧基末端肽 (ICTP)和Ⅰ型前胶原氨基端前肽 (PINP)在骨转移Ca中的临床价值。
6) carboxy terminal telopeptide of collagen type Ⅰ
Ⅰ型胶原羧基端交联肽
1.
Objective To observe the effect of atorvastain on serum levels of tumor necrosis factor a(TNF-α),interleukin 6(IL-6),matrix metalloproteases-9(MMP-9)and carboxy terminal telopeptide of collagen type Ⅰ(CITP)in patients with non-ischemic heart failure,and to investigate the possible mechanism of HMG-COA reductase inhibitor to improve cardiac function in patients with non-ischemic heart failure.
目的观察阿托伐他汀对老年非缺血性心力衰竭患者血浆肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、基质金属蛋白酶-9(MMP-9)和Ⅰ型胶原羧基端交联肽(CITP)水平的影响,探讨他汀类药物减少或延缓老年非缺血性心力衰竭发生和发展的可能机制。
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条